Explore the impact of 3D models in drug discovery and how they enhance predictive insights in pre-clinical research.

Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, announced a strategic cooperation agreement with Polpharma Biologics to advance the end-to-end development and ...

Silexion Therapeutics (SLXN) announced a strategic collaboration with Catalent (CTLT). Under the agreement, Catalent will conduct formulation ...

Adolore BioTherapeutics (”Adolore” or the “Company”) is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

We recently published a list of 13 Best Canadian Penny Stocks to Invest in Now In this article, we are going to take a look ...

Chime Biologics, a leading global CDMO that enables its partners' success in biologics, is pleased to announce a strategic ...

DELRAY BEACH, FL / ACCESS Newswire / April 23, 2025 / Adolore BioTherapeutics ("Adolore" or the "Company") is developing intracellularly-delivered neuromodulators that naturally reduce neuronal ...

Chime Biologics is a biologics service provider, from pre-clinical support and cell line development to clinical and commercial manufacturing of DS and DP. Employing our innovative and state-of ...